Barclays upgraded Newmed Energy (DKDRF) to Equal Weight from Underweight with a price target of ILS 14.20, up from ILS 11. Israeli companies navigated 2024 with “remarkable strength,” the analyst tells investors in a research note. Looking ahead, the firm sees most upside potential across banks, insurance and real estate. Inline with its relative rating approach Barclays adjusted ratings into 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue